S. A. Çifci Et Al. , "Liposomal amphotericin B related late-onset hyperphosphatemia in a pediatric patient with acute myeloid leukemia," Journal of Oncology Pharmacy Practice , vol.28, no.6, pp.1478-1482, 2022
Çifci, S. A. Et Al. 2022. Liposomal amphotericin B related late-onset hyperphosphatemia in a pediatric patient with acute myeloid leukemia. Journal of Oncology Pharmacy Practice , vol.28, no.6 , 1478-1482.
Çifci, S. A., Yalçın, N., Aksu, T., & Demirkan, K., (2022). Liposomal amphotericin B related late-onset hyperphosphatemia in a pediatric patient with acute myeloid leukemia. Journal of Oncology Pharmacy Practice , vol.28, no.6, 1478-1482.
Çifci, Sude Et Al. "Liposomal amphotericin B related late-onset hyperphosphatemia in a pediatric patient with acute myeloid leukemia," Journal of Oncology Pharmacy Practice , vol.28, no.6, 1478-1482, 2022
Çifci, Sude A. Et Al. "Liposomal amphotericin B related late-onset hyperphosphatemia in a pediatric patient with acute myeloid leukemia." Journal of Oncology Pharmacy Practice , vol.28, no.6, pp.1478-1482, 2022
Çifci, S. A. Et Al. (2022) . "Liposomal amphotericin B related late-onset hyperphosphatemia in a pediatric patient with acute myeloid leukemia." Journal of Oncology Pharmacy Practice , vol.28, no.6, pp.1478-1482.
@article{article, author={Sude Ayça Çifci Et Al. }, title={Liposomal amphotericin B related late-onset hyperphosphatemia in a pediatric patient with acute myeloid leukemia}, journal={Journal of Oncology Pharmacy Practice}, year=2022, pages={1478-1482} }